Approach to the treatment of hyperuricemia.
Poon
Samuel H
SH
Rhode Island Hospital, USA.
Hall
Harald A
HA
Zimmermann
Bernard
B
D000493:Allopurinol / Q000009:adverse effects / Q000627:therapeutic use; D000069465:Febuxostat; D006074:Gout Suppressants / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D033461:Hyperuricemia / Q000175:diagnosis / Q000178:diet therapy / Q000188:drug therapy*; D013844:Thiazoles / Q000627:therapeutic use; D014527:Uric Acid / Q000097:blood*; D014528:Uricosuric Agents / Q000627:therapeutic use; D014969:Xanthine Oxidase / Q000037:antagonists & inhibitors
D006074:Gout Suppressants; D013844:Thiazoles; D014528:Uricosuric Agents; D000069465:Febuxostat; D014527:Uric Acid; D000493:Allopurinol; D014969:Xanthine Oxidase